Clinical Trials Sponsored by Hangzhou Adcoris Biopharmacy Co., Ltd

Total 683 results

E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

A Study of QY101 Ointment in Subjects With Plaque Psoriasis

Psoriasis

China
Hangzhou Dinova EP Technology Co., Ltd

Not yet recruiting

An Exploratory Study of Focal Pulse Ablation System in the Treatment of Typical Atrial Flutter

Typical Atrial Flutter
Hangzhou Cheetah Cell Therapeutics Co., Ltd

Recruiting

NKG2D CAR-NK & Ovarian Cancer

Ovarian Cancer

China
Hangzhou Yirui Pharmaceutical Technology Co., Ltd

Completed

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers

Psoriasis | Atopic Dermatitis

United States
Hangzhou Dinova EP Technology Co., Ltd

Active, not recruiting

Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder

Atrial Fibrillation

China
Hangzhou Zede Pharma-Tech Co., Ltd.

Completed

Short-term Clinical Study of CN128 in Thalassemia Patients

Thalassemia

China
Hangzhou Dinova EP Technology Co., Ltd

Completed

Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)

Paroxysmal Atrial Fibrillation

China
Hangzhou Zede Pharma-Tech Co., Ltd.

Completed

Clinical Study of CN128 in Thalassemia Patients

Thalassemia

China
Hangzhou Dinova EP Technology Co., Ltd

Recruiting

First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder

Nonvalvular Atrial Fibrillation

China
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Not yet recruiting

A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
Hangzhou Tangji Medical Technology Co., Ltd.

Completed

Tangji Gastric Bypass Stent Study for Obesity

Obesity

China
Hangzhou Cheetah Cell Therapeutics Co., Ltd

Terminated

NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Safety and Efficacy

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Unknown

A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL

B-cell Lymphoma

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Completed

Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

China
Hangzhou Wei Chuan Foods Co., Ltd.

Completed

Immune System Stimulation by Probiotic Food Supplementation

Flu Symptom
Hangzhou Dinova Neuroscience Technology Co., Ltd

Recruiting

First-in-man Study of the Cerebrovascular Interventional Procedural Control System

Acute Ischemic Stroke

China
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

A First-in-Human Study of QY211 Gel in Adult Subjects

Atopic Dermatitis

China
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Recruiting

A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer

China
Hangzhou Tangji Medical Technology Co., Ltd.

Not yet recruiting

Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease
Hangzhou Dinova EP Technology Co., Ltd

Not yet recruiting

Study on the Safety and Effectiveness of the SnowyTM PFO Closure System

Patent Foramen Ovale

China
Hangzhou Zede Pharma-Tech Co., Ltd.

Recruiting

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

Iron Overload | Thalassemia

China
Hangzhou Tangji Medical Technology Co., Ltd.

Not yet recruiting

Tangji EU Gastric Bypass Stent Study for Obesity

Obesity
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,

Completed

A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

China
Hangzhou Zede Pharma-Tech Co., Ltd.

Completed

Long-term Clinical Study of CN128 in Thalassemia Patients

Iron Overload | Thalassemia

China
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Completed

A First-in-Human Study of QY101 Ointment in Adult Subjects

Healthy Volunteer

China
Hangzhou Nuochi Life Science Co., Ltd.

Completed

Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram

Healthy People

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Completed

Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment

Carcinoma，Non-Small-Cell Lung

China
HanAll BioPharma Co., Ltd.
Daewoong Pharmaceutical Co. LTD.

Completed

A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye (VELOS-3)

Dry Eye

United States
HanAll BioPharma Co., Ltd.
Daewoong Pharmaceutical Co. LTD.

Completed

A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes (VELOS-2)

Dry Eye

United States
Creative Biosciences (Guangzhou) Co., Ltd.
Guangzhou Xiangkang Medical Research Co., Ltd.

Completed

A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

Pneumonia | Adenocarcinoma | Small Cell Lung Cancer | Chronic Obstructive Pulmonary Disease | Non-Small Cell Lung Cancer | Lung Cancer | Tuberculosis | Chronic Bronchitis | Squamous Cell Carcinoma | Lung Neoplasm | Respiratory Tract Infection | Acute Bronchitis | Adenosquamous Carcinoma | Large Cell Carcinoma | Sarcomatoid... and other conditions

China
Creative Biosciences (Guangzhou) Co., Ltd.
Guangzhou Xiangkang Medical Research Co., Ltd.

Recruiting

A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China

Bladder Cancer | Urothelial Carcinoma | Urocystitis | Urinary Bladder Stone

China
Hangzhou NOYA MedTech Co. Ltm.

Recruiting

NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)

Heart Failure

China
Sun Yat-sen University
Hangzhou ACEA Pharmaceutical Research Co., Ltd.; Acea Bio (Hangzhou) Co., Ltd.

Unknown

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer

Non-Small Cell Lung Cancer

China
Hangzhou NOYA MedTech Co. Ltm.

Completed

Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access

Heart Diseases | Atrial Fibrillation

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Guangdong Provincial People's Hospital; Acea Bio (Hangzhou) Co., Ltd.

Active, not recruiting

Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC

Metastatic Non-small Cell Lung Cancer

China
Wuhan YZY Biopharma Co., Ltd.

Recruiting

Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody

Malignant Ascites

China
Shanghai Vitalgen BioPharma Co., Ltd.

Not yet recruiting

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency

Aromatic L-amino Acid Decarboxylase Deficiency
Shanghai Vitalgen BioPharma Co., Ltd.

Recruiting

A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b

Glutaric Acidemia Type I | Glutaric Aciduria Type I

China
JHM BioPharma (Tonghua) Co. , Ltd.

Recruiting

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Shanghai Blueray Biopharma Co., Ltd.

Not yet recruiting

Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers

Follicular Lymphoma | Diffuse Large B Cell Lymphoma | Advanced Cancer | Peripheral T Cell Lymphoma
Shenzhen Pregene Biopharma Co., Ltd.

Recruiting

Clinical Study of the Safety and Efficacy of BCMA CAR-NK

Multiple Myeloma | Immunotherapy

China
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Advanced Solid Tumors | Relapsed Or Refractory Non-Hodgkin Lymphoma

China
Wuhan YZY Biopharma Co., Ltd.

Not yet recruiting

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

NSCLC Stage IV | Malignant Pleural Effusions

China
Etern BioPharma (Shanghai) Co., Ltd

Not yet recruiting

SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors (FIRST)

Advanced Solid Tumor

United States
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

A Study to Assess YH003 in Combination With Pebolizumab and Albumin Paclitaxel Injection in Subjects With Unresectable/Metastatic Mucosal Melanoma

Mucosal Melanoma

China
Etern BioPharma (Shanghai) Co., Ltd

Recruiting

SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
RetroLead (Shanghai) BioPharma Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral HRS5685 in Healthy Subjects

Human Immunodeficiency Virus-1 (HIV-1) Infection
Shandong TheraWisdom Biopharma Co., Ltd.

Recruiting

Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies.

Advanced Malignancies

China
Adlai Nortye Biopharma Co., Ltd.

Recruiting

First in Human, Dose Escalation Study of AN4005

Advanced Solid Tumor | Advanced Lymphoma

United States, China
Adlai Nortye Biopharma Co., Ltd.

Active, not recruiting

The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC (BURAN)

Head and Neck Cancer

United States, United Kingdom, France, Hungary, Spain, Japan, Italy, Hong Kong, Taiwan, Korea, Republic of, Germany, Australia, China, Canada, Belgium, Argentina, Poland

Clinical Trials Sponsored by Hangzhou Adcoris Biopharmacy Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations